glaxo
aims
high
profit
fall
glaxosmithkline
saw
profits
fall
last
year
â£bn
bn
europes
biggest
drugmaker
says
recovery
way
cheap
copies
drugs
particularly
antidepressants
paxil
wellbutrin
weak
dollar
hit
profits
global
sales
firm
confident
new
drug
pipeline
deliver
profits
despite
failure
obesity
drug
chief
executive
jeanpierre
garnier
said
difficult
year
early
afternoon
trade
london
company
share
price
pence
mr
garnier
said
company
absorbed
â£bn
lost
sales
generics
still
managing
grow
business
continuing
success
key
products
means
look
forward
good
performance
said
also
important
year
terms
research
development
pipeline
progress
however
firm
discontinued
development
experimental
treatment
obesity
known
disappointing
clinical
trial
results
glaxo
relying
new
treatments
conditions
cancer
diabetes
depression
hivaids
allergies
lift
pace
sales
growth
several
disappointing
years
